Ouro Fino Saúde Animal Participações S.A. (BVMF:OFSA3)

Brazil flag Brazil · Delayed Price · Currency is BRL
32.21
-0.29 (-0.89%)
At close: Apr 28, 2026
40.72%
Market Cap 1.73B
Revenue (ttm) 1.22B
Net Income (ttm) 222.31M
Shares Out 53.77M
EPS (ttm) 4.13
PE Ratio 7.79
Forward PE n/a
Dividend 1.29 (3.97%)
Ex-Dividend Date Apr 17, 2026
Volume 25,600
Average Volume 11,975
Open 32.97
Previous Close 32.50
Day's Range 32.20 - 34.24
52-Week Range 20.90 - 33.00
Beta 0.22
RSI 70.76
Earnings Date May 7, 2026

About BVMF:OFSA3

Ouro Fino Saúde Animal Participações S.A., together with its subsidiaries, engages in the development, production, and sale of veterinary drugs, vaccines, and other products for production and companion animals primarily in Brazil. The company operates through three segments: Production Animals; Companion Animals; and International Operations. It manufactures and trades in medicines, including anti-inflammatories, antibiotics, anticoccidials, antimastitics, ectoparasiticides, endectocides, endoparasiticides, hemoparasiticides, inoculants, thera... [Read more]

Sector Healthcare
Founded 1987
Employees 1,086
Stock Exchange Brazil Stock Exchange
Ticker Symbol OFSA3
Full Company Profile

Financial Performance

In 2025, BVMF:OFSA3's revenue was 1.22 billion, an increase of 19.54% compared to the previous year's 1.02 billion. Earnings were 222.31 million, an increase of 65.50%.

Financial Statements

News

Q3 2024 Ouro Fino Saude Animal Participacoes SA Earnings Call Transcript

Q3 2024 Ouro Fino Saude Animal Participacoes SA Earnings Call Transcript

1 year ago - GuruFocus